​

Funding Round

Series A - Cytonus Therapeutics

Series A - Cytonus Therapeutics

Investment Firm

Overview

Cytonus is a biotech company combining AI-driven drug discovery together with a class defining drug-delivery platform called the Cargocyte

Announced Date

Nov 03, 2023

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

7

Investor Name
Participant InvestorPartners Investment
Participant InvestorProx Ventures
Participant InvestorJohn Ballantyne
Participant InvestorCreative Ventures
Participant InvestorWilson Sonsini Goodrich & Rosati

Round Details and Background

Cytonus Therapeutics raised $11703095 on 2023-11-03 in Series A

Cytonus is a biotech company combining AI-driven drug discovery together with a class defining drug-delivery platform called the Cargocyte

Company Funding History

12

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 29, 2022
Seed Round - Cytonus Therapeutics
1-1.8M
Feb 28, 2023
Venture Round - Cytonus Therapeutics
3-undefined
Nov 03, 2023
Series A - Cytonus Therapeutics
7-11.7M
Aug 31, 2023
Grant - Cytonus Therapeutics
-2.0M

Recent Activity

There is no recent news or activity for this profile.